Titel

Merkliste
1 Ergebnisse

sj-pdf-1-tan-10.1177_1756286420987941 – Supplemental materi..:

Ludwig Kappos (253872) ; Stanley Cohan (3486812) ; Douglas L. Arnold (8832665)...
https://figshare.com/articles/journal_contribution/sj-pdf-1-tan-10_1177_1756286420987941_Supplemental_material_for_Safety_and_efficacy_of_daclizumab_beta_in_patients_with_relapsing_multiple_sclerosis_in_a_5-year_open-label_study_EXTEND_final_results_following_early_termination/14131909. , 2021

Link: https://doi.org/10.25384/sage.14131909.v1

RT Journal
T1 <Title>sj-pdf-1-tan-10.1177_1756286420987941 – Supplemental material for Safety and efficacy of daclizumab beta in patients with relapsing multiple sclerosis in a 5-year open-label study (EXTEND): final results following early termination</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftsmithonian:oai:figshare.com:article_14131909&Exemplar=1&LAN=DE
				
A1 Ludwig Kappos (253872)
A1 Stanley Cohan (3486812)
A1 Douglas L. Arnold (8832665)
A1 Randy R. Robinson (10209523)
A1 Joan Holman (5170199)
A1 Sami Fam (10209526)
A1 Becky Parks (8774170)
A1 Shan Xiao (3117867)
A1 Wanda Castro-Borrero (5339651)
YR 2021
K1 Neurology and Neuromuscular Diseases
K1 Pharmacology and Pharmaceutical Sciences not elsewhere classified
K1 autoimmunity
K1 daclizumab
K1 encephalitis
K1 multiple sclerosis
JF https://figshare.com/articles/journal_contribution/sj-pdf-1-tan-10_1177_1756286420987941_Supplemental_material_for_Safety_and_efficacy_of_daclizumab_beta_in_patients_with_relapsing_multiple_sclerosis_in_a_5-year_open-label_study_EXTEND_final_results_following_early_termination/14131909
LK http://dx.doi.org/https://doi.org/10.25384/sage.14131909.v1
DO https://doi.org/10.25384/sage.14131909.v1
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)